Holen Sie sich die Stockscreener-App
4.59
10.34%
0.43
Handel nachbörslich:
4.59
Finanzdaten der Adverum Biotechnologies Inc-Aktie (ADVM)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | 1.00 | - |
Operating Expenses
|
3.39%
49.85
|
48.22 | 42.62 | 35.44 | 32.90 |
| Depreciation and Amortization |
21.67%
0.535
|
0.683 | 0.81 | 0.89 | 0.956 |
| Operating Income/Loss |
3.39%
-49.85
|
-48.22 | -42.62 | -34.44 | -32.90 |
| Income/Loss From Continuing Operations Before Tax |
4.62%
-49.19
|
-47.02 | -60.53 | -27.13 | -18.48 |
| Income/Loss From Continuing Operations After Tax |
4.62%
-49.19
|
-47.02 | -40.93 | -32.35 | -30.50 |
|
Net Income/Loss
|
4.62%
-49.19
|
-47.02 | -40.93 | -32.35 | -30.50 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.34%
21.01
|
20.94 | 0.374 | 20.88 | 20.85 |
| Diluted Average Shares |
0.34%
21.01
|
20.94 | 0.374 | 20.88 | 20.85 |
| Basic Earnings Per Share |
4.00%
-2.34
|
-2.25 | -1.98 | -1.55 | -1.46 |
| Diluted Earnings Per Share |
4.00%
-2.34
|
-2.25 | -1.98 | -1.55 | -1.46 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
5.15%
1.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):